Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bradykinin B2 receptor (BDKRB2) is a G-protein coupled receptor that plays crucial roles in inflammatory processes, pain signaling, and vascular function. Activation of the receptor by bradykinin and kallidin leads to downstream signaling through multiple G protein families, ultimately resulting in increased intracellular calcium, MAPK activation, and other cellular responses. The receptor is ubiquitously expressed and is implicated in several clinical conditions, including osteoarthritis, blood pressure regulation, and respiratory diseases, making it a potential therapeutic target for various inflammatory and pain-related conditions.
G protein activation (Gq/G11, Gi/Go, Gs), calcium mobilization, MAPK pathway activation, β-arrestin recruitment
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bradykinin B2 Receptor (BDKRB2).